Actively Recruiting
Study to Evaluate Accuracy, Usability, and Readability of the Multiplo TP/HIV Antibody Self-Test and Peer-led HIV and Syphilis Care in People Experiencing Homelessness in Toronto
Led by Unity Health Toronto · Updated on 2026-01-27
900
Participants Needed
3
Research Sites
36 weeks
Total Duration
On this page
Sponsors
U
Unity Health Toronto
Lead Sponsor
U
University of Toronto
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the Multiplo TP/HIV Self-Test to identify HIV and syphilis infections among people in Canada, especially aiming to reach those undiagnosed. This study investigates whether untrained individuals can accurately perform this self-test, which is designed to provide quick results from a fingerstick blood sample. The test is under review for use by trained healthcare professionals, while this study explores its use as a self-test by lay persons. Participants will use the Multiplo TP/HIV Self-Test on their own without prior training, following only written instructions. A trained observer will watch and record their testing process and independently interpret the self-test results. About 400 participants will also interpret ten mock test devices showing various results to assess their ability to read test outcomes. All participants will provide venous blood samples for laboratory testing with standard HIV and syphilis tests to compare accuracy. During the study, participants will complete questionnaires about the test's usability and clarity of instructions. They will return for a follow-up visit about two weeks later to receive their laboratory test results. The study measures how well the self-test agrees with laboratory results and evaluates participants' understanding and interpretation of test results. Safety and suitability will be monitored, and counselling may be provided if reactive results are found. Total study participation involves initial testing and a follow-up visit approximately two weeks later.
CONDITIONS
Brief Title
Multiplo Tp/HIV Self-Test
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Are 18 years of age or older
- Can speak, read, and write English or French
- Have presented for voluntary HIV and/or syphilis testing in clinic or community settings
- Are willing to participate in standard HIV and syphilis counselling and testing programs
- Are willing to participate in the study
- Can provide informed consent
- Can complete required testing on the assigned day
- Are willing to provide fingerstick and venipuncture blood samples for study testing
- Have unknown HIV and syphilis status (last negative test at least 3 months ago)
You will not qualify if you...
- Do not meet the inclusion criteria
- Are known HIV and/or syphilis positive
- Have ever tested positive for HIV or syphilis
- Have experience conducting rapid point-of-care tests for HIV, syphilis, or other infectious diseases
- Are familiar with the Multiplo TP/HIV Self-Test
- Are employees or immediate family of study investigators or sponsors
- Have participated in prior or concurrent HIV and syphilis self-test trials
- Are practicing healthcare professionals performing HIV rapid tests
- Have any condition making participation unsafe or unsuitable, such as inability to read, intoxication, acute sickness, or visible distress
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - 1 day
Participants perform the Multiplo TP/HIV Self-Test and provide venous blood samples for laboratory testing to determine HIV and syphilis status. Participants also complete questionnaires about usability and label comprehension. Some participants interpret mock test results.
1 visit (in-person)
Duration - Approximately 2 weeks after initial testing
Participants return to the clinic approximately two weeks later to receive their laboratory test results and may receive counselling or treatment as needed.
1 follow-up visit (in-person)
Trial Site Locations
Total: 3 locations
1
Cool Aid Community Health Centre
Victoria, British Columbia, Canada, V8W 1M8
Actively Recruiting
2
Hassle Free Clinic
Toronto, Ontario, Canada, M5B 1G3
Actively Recruiting
3
Women's Health in Women's Hands
Toronto, Ontario, Canada, M5B 1J3
Actively Recruiting
Research Team
M
Megan Cedrone, BSc, MSc
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1